Page 38 - Reference Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog: We’ve been talking about telehealth and mental health this week. Here’s both combined in one interesting and highly valued announcement today, followed by several tests – well, 3 million COVID tests a week to be exact, and, speaking of Exact Sciences, developments in the early detection tests for the other major disease that is most feared, cancer. Telehealth and Mental Health: One area where telehealth is likely here to stay is in the behavioral health space. Look no further than the latest SPAC acquisition announcement today...

Thursday, January 14, 2021 We’ve been talking about telehealth and mental health this week. Here’s both combined in one interesting and highly valued announcement today, followed by several tests – well, 3 million COVID tests a week to be exact, and, speaking of Exact Sciences, developments in the early detection tests for the other major disease that is most feared, cancer. Telehealth and Mental Health One area where telehealth is likely here to stay is in the behavioral health space. Look no further than the latest SPAC acquisition announcement today with the behavioral heal...

Backed by BioReference's national presence and infrastructure, with laboratory facilities and professionals across the country, Scarlet delivers an innovative, flexible, mobile alternative to traditional patient service centers or other draw locations when phlebotomy and other specimen collection services are needed.  Patients will no longer need to travel for laboratory services. Healthcare providers will secure vital diagnostic information about patients reliably, quickly and easily to enable a faster diagnosis.   To use Scarlet's convenient, secure and sa...

This article is an excerpt from the research magazine "Tackling Global Issues vol.3 Fighting the menace of zoonosis." Click here to see the table of...

Share this article Share this article ORCHARD PARK, N.Y., Dec. 31, 2020 /PRNewswire/ -- Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at Bills Stadium in Orchard Park. Through New York State, the Bills have been granted permission to host fans at their home Wild Card game that will be played on Jan. 9 or 10. All fans will be required to obtain a negative COVID-19 PCR laboratory-based test result within 72 hours of the ...